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Abstract Defects in energy metabolism are potential patho-
genic mechanisms in amyotrophic lateral sclerosis (ALS), a
rapidly fatal disease with no cure. The mechanisms through
which this occurs remain elusive and their understanding may
prove therapeutically useful. We used metabolomics and sta-
ble isotope tracers to examine metabolic changes in a well-
characterized cell model of familial ALS, the motor neuronal
NSC-34 line stably expressing human wild-type Cu/Zn super-
oxide dismutase (wtSOD1) or mutant G93A (G93ASOD1).
Our findings indicate that wt and G93ASOD1 expression both
enhanced glucose metabolism under serum deprivation.
However, in wtSOD1 cells, this phenotype increased supply
of amino acids for protein and glutathione synthesis, while in
G93ASOD1 cells it was associated with death, aerobic gly-
colysis, and a broad dysregulation of amino acid homeostasis.
Aerobic glycolysis was mainly due to induction of pyruvate
dehydrogenase kinase 1. Our study thus provides novel
insight into the role of deranged energy metabolism as a cause
of poor adaptation to stress and a promoter of neural cell
damage in the presence of mutant SOD1. Furthermore, the
metabolic alterations we report may help explain why mito-
chondrial dysfunction and impairment of the endoplasmic re-
ticulum stress response are frequently seen in ALS.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a progressive neurode-
generative disease affecting upper and lower motor neurons,
usually leading to death in about 3–5 years after the onset of
symptoms. Sporadic and familial forms of ALS (sALS and
fALS) are clinically very similar and have no cure. fALS is
caused by mutations in a heterogeneous group of genes [1].
Approximately 20 % of fALS and 5 % of apparent sALS
patients have mutations in the Cu/Zn superoxide dismutase
(SOD1) gene and the pathophysiological role of these muta-
tions, which cause multiple changes in the different cell types
of the central nervous system, are still not clear [1].
Rats, mice, and cells expressing mutant SOD1 proteins
have been studied extensively as a model of ALS. SOD1 is
primarily a cytosolic protein, but is also present in mitochon-
dria, where it localizes mostly in the intermembrane space [2].
This enzyme catalyzes the dismutation of the superoxide rad-
ical, and therefore has a function in oxidative stress protection.
SOD1 has also been shown to transmit signals from oxygen
and glucose to regulate respiration [3].
Oxidative stress is clearly associated with disease onset in
ALS and this seems to be just one aspect of a complex process
leading to neurodegeneration [4, 1]. The mitochondria are the
main source of reactive oxygen species (ROS), but they also
provide the majority of metabolic energy through ATP formed
by oxidative phosphorylation. Motor neuron mitochondria
have been found to be morphologically and functionally al-
tered in ALS patients and in mice and cells expressing mutant
forms of SOD1 [4, 5]. These models showed bioenergetic
defects [4, 6], and an early energy imbalance affecting surviv-
al was observed in the mutant G86RSOD1 transgenic mouse
[7]. Abnormalities of energy metabolism are considered a po-
tential factor contributing to the ALS disease phenotype as
weight loss, hypermetabolism, and hyperlipidaemia have been
observed in ALS patients [8]. In the central nervous system,
energy homeostasis relies on metabolic interactions among
different cell types, each with peculiar expression/regulation
of energy metabolism enzymes and transporter proteins [9].
Glucose is the main neuronal energy source, but neurons also
use other substrates, including lactate, the main end-product of
aerobic glycolysis [10]. Interestingly, the failure of lactate
exchange between oligodendrocytes and axons has been
shown to contribute to motor neuron death in ALS patients
and in G93ASOD1 mice [11].
Little information is available on whether or how mutant
SOD1 in each cell type contributes to dysregulating energy
metabolism, and its specific role in motor neuron death.
Investigations into alterations to cellular metabolism associat-
ed with ALS may benefit from a comprehensive metabolomic
approach. Metabolomic analysis has previously been applied
to biofluids such as cerebrospinal fluid, where unique profiles
were observed in patients carrying mutant SOD1 [12].
In this study, we examined alterations to cellular metabo-
lism in a previously characterized motor neuronal ALS model
system, the murine neuroblastoma×spinal cord (NSC-34) cell
line, stably expressing human wild-type (wt) SOD1
(wtSOD1) or mutant G93A (G93ASOD1) [13]. We employed
a comprehensive metabolomic approach, involving
untargeted profiling and stable isotope incorporation analysis
using 1H nuclear magnetic resonance (1H NMR) spectroscopy
and gas-chromatography-mass spectrometry (GC-MS). The
untransfected and the SOD1-transfected NSC-34 cell lines
were characterized under serum deprivation, which requires
adaptation to oxidative and metabolic stress [14]. Previous
work in this model showed that this stress was more toxic to
motor neuronal cells expressing the G93ASOD1 protein com-
pared to wtSOD1 [13]. Our results show that in response to
serum deprivation, wtSOD1 ensured an increased supply of
amino acids for protein and glutathione synthesis through en-
hanced glucose metabolism while this metabolic phenotype
led to impairment of mitochondrial function and amino acid
homeostasis when G93ASOD1 was expressed instead.
Materials and Methods
Materials
Flasks and plates were obtained from Corning Inc.
High-glucose D-MEM and fetal bovine serum (FBS)
were from Lonza, and high-glucose D-MEM without phenol
red, geneticin (G418 sulfate), pyruvate, L-glutamine and
penicillin/streptomycin were from GIBCO, Invitrogen.
[U-13C6]glucose and [U-
13C5]glutamine were from
Cambridge Isotope Laboratories (Andover, MA, USA).
Sodium dichloroacetate (DCA) was from Sigma-Aldrich.
The primary antibodies were hexokinase II, glyceraldehyde
3-phosphate dehydrogenase, pyruvate kinase isozyme M2,
pyruvate dehydrogenase α subunit (Glycolysis Antibody
Sampler Kit), lactate dehydrogenase A (#2012), all from
Cell Signaling; pyruvate dehydrogenase kinase 1 (KAP-
PK112) from Stressgen; hypoxia-inducible factor 1α from
Novus Biologicals (NB100-479); peroxisome proliferator-
activated receptor γ co-activator-1α from Santa Cruz
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Biotechnology (sc-13067); glutamine synthetase from Abcam
(ab49873); monocarboxylate transporter 1 from Millipore
(#AB1286-I); actin from Millipore (MAB 1501).
Motor Neuronal ALS Model
NSC-34 is a hybrid cell line (mouse neuroblastoma
N18TG2×mouse embryonic spinal cord motor neurons) that
expresses motor neuron features without the need for inducing
agents in the medium [15] and is a well-characterized
in vitro system for motor neuron biology. This cell line
has been widely used to obtain models to investigate
mechanisms of motor neuronal degeneration associated
with mutant forms of human SOD1. This study investigated
the effects of the glycine 93 to alanine (G93A) SOD1 point
mutation.
Untransfected NSC-34 and themonoclonal NSC-34 lines sta-
bly expressing wtSOD1 (WT-NSC) and G93ASOD1 (G93A-
NSC) used in this study [13] were grown in high-glucose
DMEM supplemented with 5 % heat-inactivated FBS, 1 mM
glutamine, 1mMpyruvate, and antibiotics (100 IU/mLpenicillin
and 100 μg/mL streptomycin). The WT-NSC and G93A-NSC
cell lines were kept in selection by adding 0.5 mg/mL geneticin.
The lines were cultured simultaneously, subcultured in parallel
every seven days and never maintained beyond passage 20 in
order to limit any potential effects of senescence.
Treatments and Isotopic Labeling
The standard treatment was culture without serum for 22 h.
The cell lines, all at the same passage number, were
seeded into multi-well plates at a density of 7630
cells/cm2 per well in the standard culture medium
with/without geneticin and maintained at 37 °C in a humidi-
fied atmosphere with 5 % CO2 for 96 h. Themediumwas then
removed and all the lines were exposed for 22 h to medium
without geneticin, phenol red, and FBS. Medium and cells
were then processed according to the protocol of each
analysis.
For the experiments with DCA, the compound (2.5 or
5.0 mM for 22 h) was added to cells when the mediumwithout
FBS was added.
For isotopic labeling experiments, cells were cultured in
six-well plates for 96 h in standard culture medium. The
medium was then removed and cells were rinsed with 1X
PBS. Cells were then cultured for 22 h in DMEM with no
FBS containing either [U-13C6]glucose (25 mM) or
[U-13C5]glutamine (1mM). The media was collected and cells
were rinsed with cold Ringer’s solution. Metabolites were
extracted and metabolism was quenched by immediately
adding cold methanol. The cell extracts were dried down
using a centrifugal evaporator, and the media and cell extracts
were stored at −70 °C until metabolomic analysis.
Replicate plates were prepared to determine the protein
content, with the bicinchoninic acid (BCA) protein assay kit
(Pierce, Rockford, IL, USA) for normalization.
1H NMR Spectroscopy of Cell Culture Media
Five hundred fifty microliters of culture medium and 50 μL of
11.6 mM sodium 3-trimethylsilyl-[2,2,3,3-2H4]-1-propionate
(TSP) in deuterium oxide (D2O) as internal standard were
mixed and transferred to glass 5-mm NMR tubes for analysis.
High-resolution 1H NMR spectra of cell culture media were
acquired at 14.1 T (600.13MHz 1H frequency) using a Bruker
AVANCE 600 spectrometer (BrukerBiospin, Rheinstetten,
Germany). All spectra were acquired using a CPMG pulse
sequence, and the sum of 64 free induction decays (FIDs)
were collected into 64 k data-points with a spectral width of
12,019.230 and 0.3 Hz line broadening.
GC-MS of Intracellular Metabolites
Aqueous metabolites were separated from the intracellular
extract using a 2:1:3 chloroform/methanol/water extraction
method. The aqueous portion of the extract was separated
and lyophilized before analysis.
Samples for metabolic profiling were derivatised for
GC-MS by a two-step methoximation/silylation derivatisation
procedure. 2,3,3-d3-Leucine (20 μL, 1 mM) and
[U-13C6]glucose (20 μL, 1 mM) were added to the samples
as derivatization standards. The dried samples were first
methoximated with a solution of 20 mg/mL methoxyamine
hydrochloride (20 μL) in anhydrous pyridine at
30 °C for 90 min, then silylated with N-methyl-N-
trimethylsilyltrifluoroacetamide (MSTFA) with 1 %
trimethylchlorosilane (TMCS; 80 μL) at 37 °C for 30 min.
After derivatization, 2-fluorobiphenyl in anhydrous pyridine
(10 μL, 1 mM) was added to the samples as an injection
standard.
Samples for stable isotope incorporation analysis
were derivatised for GC-MS with a similar two-step
methoximation/silylation procedure, but using 80 μL of
N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide
with 1 % tert-butyldimethylchlorosilane at 70 °C for
60 min instead of MSTFA with 1 % TMCS.
GC-MS analysis was done on an Agilent 7890 gas chro-
matograph connected to an Agilent 5975 MSD (Agilent
Technologies UK Ltd.). Samples were injected with an
Agilent 7683 autosampler injector into deactivated splitless
liners using the FiehnLib settings [16].
Metabolomic Data Analysis
1H NMR spectra were imported and manipulated in Matlab
(Mathworks, Natick, MA, USA) using in-house code for
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automatic phasing, baseline correction, and referencing chem-
ical shifts to the TSP resonance at δ 0. The observed
resonances were assigned to specific metabolites by database
matching using the Chenomx NMR suite (Chenomx Inc.,
Alberta, Canada) and the Human Metabolome Database
(HMDB).
GC–MS profiling data were processed by deconvolution
with AMDIS using the Fiehn library, followed by an addition-
al step as previously described [17] for visual inspection of
peak quality (including match to retention time) and
back-filling the sample matrix so that all metabolites
had a numerical value for all samples, based on the
quantitation ion for each metabolite, taken from the Fiehn
library. Data were normalized to internal standards and sample
protein content.
GC-MS stable isotope incorporation data were processed
with an in-house MatLab package (developed by Dr. Gregory
Tredwell) for the quantification of mass isotopomer distribu-
tions and correction for natural isotope abundances. Further
processing and normalization was carried out on R.
MTTAssay
Reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetra-
zolium bromide (MTT) to formazan crystals by cellular dehy-
drogenases was used as a measure of the number of living
cells, as previously described [13].
Caspase Activity
Caspase 3/7 activity was determined with a luminescence as-
say (Caspase-Glo 3/7 Assay, Promega) according to the man-
ufacturer’s protocol.
Lactate Release
Lactate release in the culture medium was determined with a
spectrophotometric method adapted to analysis with a 96-well
plate, as previously described [18].
SDS-PAGE and Western Blot
The cell lines were grown and treated in 12- or 6-well plates as
previously described. The treated plates were put on ice, the
medium was removed and each well was washed twice with
PBS 1X. Thirty to fifty microliters of RIPA buffer contain-
ing protease-(P8340, Sigma-Aldrich) and phosphatase-
inhibitor (PhosSTOP, Roche Applied Science) cocktails were
added to each well; the plates were then left on ice for 10 min.
Cell lysates were collected, left on ice for 30 min, vortexed
and centrifuged at 4 °C at 8000×g for 10 min. The superna-
tants were stored in aliquots at −80 °C until used to determine
the expression levels of the proteins of interest. For nuclear
extracts, cells were lysed in NE-PER extraction reagent
(Pierce) according to the manufacturer’s protocol.
Proteins (30–50 μg) were separated by electrophoresis on
polyacrylamide gels (7.5–12 %), then electroblotted on nitro-
cellulose membranes. The blots were exposed to the primary
antibodies and to the appropriate HRP-conjugated secondary
antibodies. Actin was used as a loading control. Protein bands
were detected with the ECL detection system (Amersham
Biosciences, Little Chalfont, UK). Films were scanned and
band intensities were obtained with QuantityOne (Bio-Rad).
Statistical Analysis
The statistical significance of the data was tested by one-way
ANOVA followed by Tukey’s post hoc test. Metabolomic data
were subjected to Benjamini and Hochberg False-Discovery
Rate (FDR) correction for multiple testing. All data are pre-
sented as mean ± SEM unless otherwise stated. Statistical
analyses were done with GraphPad Prism version 6.01 or in
the R statistical environment.
Results
Serum Deprivation Causes Selective Cytotoxicity
and Increased Lactate Production in NSC-34 Cells
Expressing G93ASOD1
The WT-NSC and the G93A-NSC cell lines used in this study
have been described previously [13]. Serum deprivation is a
stress requiring adaptation to oxidative and metabolic stress.
Culturing the cell lines without serum for 22 h led to a statis-
tically significant loss of cell viability only in the G93A-NSC
(18 % decrease compared to culture in medium with 5 %
serum, Fig. 1a). This loss of viability was preceded by a 2.5-
fold increase in caspase 3/7 activity compared to NSC-34 and
WT-NSC (p<0.001, Fig. 1b). The increased susceptibility of
G93ASOD1 motor neuronal cells to serum deprivation [14,
13], as well as the caspase-inducing activity of mutant SOD1,
has previously been reported. This pointed to mitochondrial
involvement in the death of motor neurons, although death
was driven by a caspase-independent pathway [19]. Previous
work in the same cell model showed no difference in caspase
activation among the three lines after just 4 h of serum depri-
vation [20], indicating that caspase activation occurred after
longer exposure to serum deprivation, and not under culture
with 5 % FBS.
We reported that high extracellular lactate levels are a phe-
notypic marker of altered metabolic response to stress in cells
expressing a high or low level of G93ASOD1 [18, 20]. Initial
assessments of glycolytic rates through spectrophotometric
measurements of lactate in the medium showed significantly
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lower levels in culture without serum than with serum for all
the cell lines, as expected in a condition that slows prolifera-
tion (Fig. 1c, p<0.001). However, lactate was significantly
higher in the medium of the WT-NSC and G93A-NSC than
the NSC-34 both with serum (+51 and +110 %, respectively)
and without (+79 and +161 %). In addition, lactate levels in
the G93A-NSC line were significantly higher than that of the
WT-NSC (+39 % with serum and +46 % without, Fig. 1c).
These results suggest increased glycolysis in the SOD1-
transfected lines compared to the untransfected NSC-34, with
the effect being more marked in G93A-NSC than WT-NSC,
and in culture without serum. As serum deprivation revealed
the differences in toxicity of the mutant SOD1, we further
characterized the metabolic phenotype of the cells in this cul-
ture condition.
Metabolic Profiling Reveals Increased Levels of Glycolysis
and Glutaminolysis in the G93A-NSC Line
We first profiled the extracellular metabolome after serum
deprivation for 22 h through 1H NMR spectroscopy of the cell
media. The consumption of glucose in the G93A-NSC line
was 37 % higher than in the NSC-34 (p<0.001), with WT-
NSC showing intermediate levels (Fig. 2a). We confirmed the
progressively higher lactate production in G93A-NSC com-
pared to WT-NSC and in WT-NSC compared to NSC-34
(Fig. 2b). In parallel, alanine and formate levels were both
higher in the media from the G93A-NSC line (+109 and +
29 %, respectively) than from WT-NSC, and in the media
from WT-NSC (+197 and +137 %) than from NSC-34. The
same trend was observed in these metabolites in media of the
G93A-NSC after culture in 5 % FBS (Supplementary Fig. 1),
indicating that these changes were not solely due to caspase
activation. Normalizing metabolite release to glucose con-
sumption, which gives a molar ratio independent of cell num-
ber, confirmed the significant increases in extracellular lactate
and alanine in G93A-NSC compared to WT-NSC (+54 and
+78 %, respectively; Fig. 2c). Since both metabolites can be
derived directly from pyruvate, this suggested a different fate
of glucose-derived pyruvate in the lines expressing wt- or
G93ASOD1. Overall, these results indicated that while
wtSOD1 promoted glycolysis, G93ASOD1 may further in-
crease lactate and alanine formation from glucose. The signif-
icant differences in formate release into the medium across all
three lines, as well as the significant increase in the ratio of
formate release to glucose uptake is of interest, as formate
plays a key role in cellular one-carbon metabolism, although
the biological impact of these changes will require further
investigation.
Glutamate levels in the media ofWT-NSC and G93A-NSC
lines were lower (−54 and -35 %, respectively, p<0.01) com-
pared to NSC-34. However, glutamate levels were higher in
G93A-NSC than WT-NSC (+41 %, p<0.05). There were no
significant differences in the consumption of glutamine from
the medium among the three lines, although the ratios of glu-
tamate produced to glutamine consumed were significantly
different (NSC-34>G93A-NSC>WT-NSC; Fig. 2d). These re-
sults suggest that SOD1might regulate glutamate metabolism,
Fig. 1 Serum deprivation causes selective cytotoxicity, caspase 3/7
activation, and increased lactate formation in G93ASOD1 cells. a The
viability of the NSC-34, WT-NSC, and G93A-NSC cell lines was
evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium
bromide (MTT) assay after culture with or without 5% fetal bovine serum
(FBS) for 22 h. Percentages of the MTT conversion after culture with
serum (100%; n=12) are shown. bActivation of caspase 3/7 of the NSC-
34, WT-NSC, and G93A-NSC cell lines cultured without 5 % serum for
17 h. Values are percentages of the NSC-34 activity (100 %; n=15). c
Levels of lactate in the medium (μmol/mg of protein; n=8) of the NSC-
34, WT-NSC, and G93A-NSC cell lines cultured with or without 5 %
serum for 22 h. All values are mean ± s.e.m. For each parameter,
statistical significance of differences was assessed by one-way ANOVA
and Tukey’s post hoc test comparing the levels of the different cell lines
with or without 5 % serum (respectively ###p<0.001 and ***p<0.001)
or the level in each cell line without 5 % serum versus respective with 5%
serum (●●p<0.01; ●●●p<0.001)
2226 Mol Neurobiol (2016) 53:2222–2240
and that mutant G93ASOD1 increased the extracellular accu-
mulation of glutamate compared to wtSOD1.
To confirm the source of extracellular lactate and
alanine, we cultured the cell lines in [U-13C6]glucose or
[U-13C5]glutamine under serum deprivation and characterized
the culture media by 1H NMR spectroscopy (Fig. 3a). The
vast majority of lactate and alanine (∼80 %) came from glu-
cose in all lines (Fig. 3b) and there were only very minor
differences in the fraction derived from either glucose or glu-
tamine between WT-NSC and G93A-NSC (Fig. 3b).
We then probed the intracellular metabolite profile using
GC-MS analysis of cellular extracts. There were no significant
differences among the three cell lines in three out of four
detectable glycolytic intermediates (glyceraldehyde-3-phos-
phate, 3-phosphoglycerate, and dihydroxyacetonephosphate,
Fig. 4a) although the level of 3-phosphoglycerate, the glyco-
lytic precursor of serine, was 70-80 % higher in WT-NSC and
G93A-NSC than in NSC-34. However, levels of phosphoenol-
pyruvate (PEP) were strikingly higher only in the WT-NSC
line (+261 and +162 % compared to NSC-34 and G93A-NSC,
respectively, p<0.001, Fig. 4a). Pyruvate, the glycolytic pre-
cursor of lactate, was significantly elevated in the WT-NSC
and G93A-NSC lines compared to NSC-34 (+178, and +
261 %, respectively, Fig. 4b). The glycolytic products lactate
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Fig. 2 Extracellular metabolome
characterization reveals
regulation of glycolysis and
glutaminolysis with expression of
wt- and G93ASOD1. The NSC-
34, WT-NSC, and G93A-NSC
cell lines were cultured for 22 h
without serum, the media was
collected and metabolites were
determined by 1H NMR
spectroscopy. Negative values
indicate consumption from the
media and positive values
indicate net release. Lactate,
alanine, formate, and glutamate
are not present in fresh culture
medium. Changes in
concentrations of a glucose and
pyruvate, b lactate, alanine, and
formate compared to fresh
medium. c Ratios of lactate,
alanine, and formate produced per
unit of glucose consumed. d
Glutamine consumption,
glutamate production, and ratio of
glutamate produced per unit of
glutamine consumed. All values
are mean ± s.e.m. (n=4,*p<0.05,
**p<0.01, ***p<0.001 after one-
way ANOVAwith False-
Discovery Rate (FDR) correction
for multiple testing and Tukey’s
post hoc test)
Mol Neurobiol (2016) 53:2222–2240 2227
and alanine were also higher in the WT-NSC and G93A-NSC
than the NSC-34 line (Fig. 4b). Consistent with results shown
in Fig. 2, these findings indicate increased glycolytic flux in
the transfected lines (which increased lactate and alanine
production) and that the differences between wt- and
G93ASOD1-expressing cells might be due to different regu-
lation of pyruvate metabolism after the formation of PEP and
not to a change in the upstream steps of glycolysis.
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There was a trend towards higher intracellular concentra-
tions in four out of six detectable tricarboxylic acid
(TCA) cycle intermediates for both WT-NSC and G93A-
NSC compared to NSC-34, including citrate and isocitrate
(+30–40 %, n.s.) and fumarate and malate (+145–305 %, sta-
tistically significant, Fig. 5). Elevated cytosolic fumarate can
create a pseudohypoxic state, characterized by activation of
hypoxia-inducible factor 1α (HIF-1α) with consequent in-
creases of glycolysis and repression of respiration in normoxic
conditions [21, 22]. The fumarate and malate levels
were slightly lower in the G93A-NSC line than in
WT-NSC (−25 and −39 %). TCA cycle enzymes are regu-
lated through product inhibition, so accumulation of TCA
cycle intermediates, particularly citrate, may cause a decrease
in the metabolic activity of the TCA cycle with wt- and
G93ASOD1 expression. This is consistent with diversion of
pyruvate from the TCA cycle towards lactate and alanine
synthesis.
We then used GC-MS to characterize the incorpora-
tion of stable isotopes into intracellular metabolites from
[U-13C6]glucose and [U-
13C5]glutamine and confirmed
that ∼60 % of pyruvate, lactate, and alanine carbons were
glucose-derived in parental NSC-34 cells (Fig. 6). This frac-
tion rose to ∼80 % in WT-NSC and G93A-NSC, with only
alanine enrichment from glucose showing any (minor) differ-
ence between the G93A-NSC and theWT-NSC (77 and 79%,
respectively). Levels of PEP derived from glucose remained
unchanged (∼90%) irrespective of wt- or G93ASOD1 expres-
sion, and levels of glutamine-derived carbonwere consistently
low (<10 %) for all metabolites (Fig. 6).
We next examined 13C enrichment in the intracellular pools
of TCA cycle intermediates (Fig. 7). For citrate, isocitrate,
fumarate, and malate, the contribution of carbon from glucose
(∼40–55 %) was greater than for glutamine (10–20 %) across
all cell lines, whereas the contribution (20–25 %) was approx-
imately the same for succinate. The reduction in the fraction of
succinate derived from glucose, as well as the corresponding
increase in the fraction derived from glutamine when
compared to isocitrate indicated that the main entry
point of glutamine carbon into the TCA cycle was
through α-ketoglutarate after initial conversion into gluta-
mate. We saw significant increases in glucose-derived carbon
in fumarate and malate for both WT-NSC and G93A-NSC
(Fig. 7), complementing the larger pool size of these metabo-
lites (Fig. 5), as well as a significant reduction of glucose-
derived carbon in citrate in the G93A-NSC line compared to
WT-NSC (Fig. 7). However, although these changes were
significant, the differences were very small, and the biological
impact of these changes will still require further investigation.
Closer examination of the mass isotopologue distributions
for citrate (Supplementary Fig. 2a) in the presence of
[U-13C6]glucose indicated that this effect was primarily driven
by a reduction of the M+5 isotopologue fraction with a
concomitant increase in theM+0 species, but this specific effect
Lactate
0
100
200
300
400
*
**
Alanine
0
500
1000
1500 **
Glyceraldehyde-3-phosphate
0
50
100
150
200
%
 In
te
ns
ity
 v
s 
N
S
C
-3
4
Dihydroxyacetone
phosphate
0
50
100
150
3-phosphoglycerate
0
50
100
150
200
250
Pyruvate
0
100
200
300
400
500
%
 In
te
ns
ity
 v
s 
N
S
C
-3
4
**
***
Phosphoenolpyruvate
0
100
200
300
400
500
*** ***
a
b
NSC-34
WT-NSC
G93A-NSC
Fig. 4 Intracellular levels of pyruvate and its metabolites lactate
and alanine are high in cells expressing human SOD1. The NSC-
34, WT-NSC, and G93A-NSC cell lines were cultured for 22 h without
serum. Intracellular glycolytic metabolites were measured byGC-MS and
expressed as percentages of the levels in the untransfected NSC-34
line. a Levels of the glycolytic intermediates glyceraldehyde-3-
phosphate, 3-phosphoglycerate, dihydroxyacetone phosphate, and
phosphoenolpyruvate. b Levels of the glycolytic products pyruvate,
lactate, and alanine. All values are mean ± s.e.m. (n=6,*p<0.05,
**p<0.01, ***p<0.001 after one-way ANOVA with FDR correction
for multiple testing and Tukey’s post hoc test)
Mol Neurobiol (2016) 53:2222–2240 2229
could not be easily rationalized. Entry of 13C from glucose
through pyruvate would generate mass isotopomers with mass
M+2, increasing up to M+6 with repeated cycling through
the TCA cycle with no M+1 produced (Supplementary
Fig. 3), which was consistent with our findings. However,
anaplerotic flux through pyruvate carboxylase could also pro-
duce additional M+3 and M+5. Anaplerosis from glutamine
through α-ketoglutarate would generate mass isotopologues
with mass M+4, decreasing to M+0 with repeated cycling
through the TCA cycle but with no M+3 produced
(Supplementary Fig. 4), again consistent with our findings
(Supplementary Fig. 2b). Reductive carboxylation would gen-
erate an accumulation of the M+5 mass isotopomer of citrate
after incubation with [U-13C5]glutamine, which we did not
observe (Supplementary Fig. 2b).
wt- andG93ASOD1 Expression in NSC-34 Cells Stabilizes
HIF-1α and Increases Expression of Glycolytic Enzymes
Our metabolomic data provided direct evidence that wtSOD1
expression in NSC-34 cells under serum deprivation increased
glycolysis to lactate, with accumulation of intracellular pyru-
vate, PEP, fumarate, and malate derived from glucose.
Expression of G93ASOD1 recapitulated this phenotype but
further increased lactate production, apparently by shifting
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some of the flow of pyruvate from entry into the TCA cycle
towards conversion to lactate and not by regulating upstream
steps in glycolysis. To validate these hypotheses, we measured
the protein expression levels of the glycolytic enzymes glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH) and the in-
ducible forms of hexokinase 2 (HKII), pyruvate kinase M2
(PKM2), and lactate dehydrogenase A (LDHA). Levels of
HKII, which regulates the first step of glycolysis, were slightly
higher in the WT-NSC and G93A-NSC than in NSC-34
(+49 %, p<0.05 and +63 %, p<0.01, respectively, Fig. 8a),
consistent with the increase in glycolytic flux in these lines.
GAPDH, which catalyzes the oxidation of glyceraldehyde-3-
phosphate alongside the reduction of NAD+, showed no sig-
nificant changes (Fig. 8b). PKM2 levels were slightly but
significantly higher (+20 %) in both the WT-NSC and
G93A-NSC than in NSC-34 (Fig. 8c), which may contribute
in part to the higher intracellular pyruvate in the WT-NSC and
G93A-NSC (Fig. 4). The increase in the M2 isoform of pyru-
vate kinase may also indicate a more subtle regulation of py-
ruvate kinase activity as this isoform responds not only to the
availability of its substrate but also to the upstream glycolytic
intermediate fructose-1,6-biphosphate, the amino acid serine,
and phosphorylation events [23, 24]. LDHA, which reduces
pyruvate to lactate at the expense of NADH oxidation, was
significantly higher (+20 %, p<0.01) only in the G93A-NSC
line compared to NSC-34 (Fig. 8d), which may contribute to
the higher lactate concentration in the medium of the G93A-
NSC.
The higher levels of HKII and PKM2 proteins in the WT-
NSC and G93A-NSC, and of LDHA in the G93A-NSC re-
semble the cell-autonomous reprogramming of glucose and
energy metabolism activated by HIF-1α. Expression of HIF-
1α protein in the cell nuclei was significantly higher in both
the WT-NSC and G93A-NSC than in NSC-34, indicating that
SOD1 expression activated a pseudohypoxic state (Fig. 9a).
However, there was no significant difference between theWT-
NSC and G93A-NSC.
We then determined the levels of the peroxisome
proliferator-activated receptor γ co-activator-1α (PGC-1α),
which is involved in the promotion of mitochondrial biogen-
esis and respiration [25] but also regulates ROS removal under
oxidative stress [26]. Nuclear PGC-1α protein tended to be
higher in theWT-NSC andG93A-NSC (+61% n.s. and +96%
p<0.001, respectively, Fig. 9b) than in NSC-34. This mirrored
the increases in glycolysis, suggesting that PGC-1α upregu-
lation may be a response to enhance clearance of oxidative
stress caused by serum deprivation rather than to enhance
mitochondrial respiration.
Increased Lactate Accumulation in the G93A-NSC Cell
Line Is Associated with Pyruvate Dehydrogenase Kinase 1
Induction
To further investigate the cause of lactate accumulation, we
investigated whether the entry of pyruvate into the TCA cycle
in the G93A-NSC was limited by the restriction of pyruvate
dehydrogenase complex activity, which metabolizes pyruvate
to acetyl-CoA. This complex comprises three enzymes, the
first being pyruvate dehydrogenase; the activity of the com-
plex is regulated by the expression of its constituent proteins
or by phosphorylation/dephosphorylation of the α subunit of
pyruvate dehydrogenase (PDH) [27]. The expression of PDH
protein was not significantly modified in any of the cell lines
after serum deprivation (Fig. 10a). Pyruvate dehydrogenase
kinase 1 (PDK1) is the main inhibitory kinase regulating
PDH activity in neurons and astrocytes [28] and its induction
attenuates ROS formation by the mitochondrial electron trans-
port chain [29]. In previous studies, we found that a high level
of PDK1 protein was a response to stressful conditions in
NSC-34 cells expressing high/low levels of G93ASOD1
[18, 20]. Similarly, after 22 h of serum deprivation, PDK1
protein levels were significantly higher in the G93A-NSC line
(Fig. 10b) than in NSC-34 (+137 %) or WT-NSC (+109 %).
We then compared PDK1 protein levels of each cell line
after 3 h and after 22 h of serum deprivation (Fig. 10c). There
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was a significant increase (+50 %) in the NSC-34 and WT-
NSC lines, but not in the G93A-NSC (+25 %). This suggests
that culture without serum may favor an increase in PDK1 in
all the cell lines, but this was not the main factor driving PDK1
induction in the G93A-NSC, where after 22 h, PDK1 levels
were significantly higher than both NSC-34 and WT-NSC
(Fig. 10b). To investigate the role of PDH and PDK1 in the
lactate accumulation, we treated the WT-NSC and G93A-
NSC lines with DCA, an inhibitor of PDKs that per-
mits full activity of PDH [30]. Treatment with 5 mM
DCA for 46 h significantly reduced lactate in the medium of
the G93A-NSC line (Fig. 10d). Lower concentrations and
shorter treatments with DCA were not sufficient to observe
changes in extracellular lactate. DCA treatment did not signif-
icantly modify the viability of the cell lines (Supplementary
Fig. 5). We also considered the possibility that lactate trans-
porters were upregulated, but there were no changes in the
protein expression level of the monocarboxylate transporter
1 (MCT1) across the cell lines (Supplementary Fig. 6).
However, cells tightly regulate levels of intracellular lactate
to maintain pH, as acidification from intracellular lactate ac-
cumulation can limit the glycolytic capacity of cells [31].With
the elevation of glycolysis from SOD1 overexpression leading
to increased lactate, and the further increase from the inacti-
vation of PDH by PDK1 in the G93A-NSC line, the cell lines
may also engage in the export of the lactate that exceeds the
cell’s buffering capacity and tolerable pH limits through in-
creased monocarboxylate transporter activity. This would be
consistent with the increase in extracellular lactate observed in
WT-NSC and further in G93A-NSC (Figs. 1 and 2) together
with the increase in intracellular lactate in both SOD1-
overexpressing lines (with no difference in WT-NSC and
G93A-NSC; Fig. 4b). Overall, results strongly implicate
PDK1 inactivation of PDH as an upstream cause of the more
Fig. 8 Protein expression of
glycolytic enzymes of NSC-34,
wtSOD1, and G93ASOD1 cells.
The NSC-34, WT-NSC, and
G93A-NSC cell lines were
cultured for 22 h without serum.
Protein expression of a
hexokinase II (HK II; n=9), b
glyceraldehyde 3-phosphate
dehydrogenase (GAPDH; n=3), c
pyruvate kinase M2 isoform
(PKM2; n=6), and d lactate
dehydrogenase A (LDHA; n=18)
were determined by Western blot
and normalized to actin. A
representative Western blot is
shown for each protein. All values
are percentages of the NSC-34
level and are mean ± s.e.m.
(*p<0.05 and **p<0.01 after
one-way ANOVA and Tukey’s
post hoc test)
2232 Mol Neurobiol (2016) 53:2222–2240
marked accumulation of intracellular pyruvate and extracellu-
lar lactate in the G93A-NSC line than in WT-NSC (Figs. 1, 2,
and 4b).
Intracellular Levels of Amino Acids Are Lower
in the G93A-NSC Line Than in the WT-NSC and NSC-34
During serum deprivation, promotion of cell survival involves
the activation of the integrated stress response (ISR), which
ensures the supply of amino acids for protein and glutathione
biosynthesis [32, 33]. We therefore examined the intracellular
concentrations of several amino acids in the cell lines.
Broadly, the changes in amino acid levels (Fig. 11) could
be divided into two groups. The first group showed no signif-
icant difference with wtSOD1 expression compared to the
untransfected NSC-34, but had lower levels specifically with
G93ASOD1 expression. This group was dominated by
essential/semi-essential amino acids including the branched-
chain amino acids leucine, isoleucine, and valine (significant
decreases in G93A-NSC of 51, 51, and 53 % vs. NSC-34
respectively, p<0.05) and cysteine (−56 % compared to NSC-
34, p<0.001), as well as proline, histidine, lysine, methionine,
phenylalanine, threonine, tryptophan, and tyrosine (non-sig-
nificant decreases ranging 10–55 %, Fig. 11a). In contrast, the
second group of amino acids exhibited large increases
with wtSOD1 expression compared to NSC-34. These
amino acids can be synthesized de novo and are in-
volved in neurotransmission, as they are precursors in
the synthesis or act directly as neurotransmitters
(Fig. 11b). We observed significantly higher levels of serine
(+164 %), N-acetyl aspartate (+106 %), asparagine (+105 %),
glutamine (+511 %), and glutamate (+100 %) and non-
significant increases in glycine (+47 %) and aspartate
(+77 %). However, this effect was absent or less pronounced
in the G93A-NSC line (−40 %, −36 %, −78 %, −68 % in the
G93A-NSC compared to WT-NSC for serine, N-acetyl aspar-
tate, glutamine, and asparagine, respectively, p<0.05), with no
significant increases compared to NSC-34. These results indi-
cate a widespread decrease in amino acid availability in the
G93ASOD1-expressing cells under serum deprivation com-
pared to the wtSOD1.
Investigation of the 13C enrichment of amino acid pools
through culture with labeled glucose and glutamine confirmed
that for five amino acids there was significant de novo syn-
thesis: these were glutamine, glutamate, serine, glycine, and
cystathionine (precursor of cysteine). After incubation with
labeled glucose at least 50 % of the intracellular glutamate
was enriched with 13C, with a small but significant increase
for G93A-NSC compared to NSC-34 (+0.9 %, p<0.05).
Interestingly, a smaller proportion of intracellular glutamate
(20–25 %) was derived from glutamine, which is the canoni-
cal pathway for glutamate synthesis in neurons in vivo. There
was substantial 13C enrichment from [U-13C6]glucose of in-
tracellular glutamine, and levels differed significantly between
the lines (32 % in NSC-34; a decrease to 18 % in WT-NSC
and 24 % in G93A-NSC, p<0.05; Fig. 12a). When incubated
with [U-13C5]glutamine, the pattern of
13C enrichment in in-
tracellular glutamine was reversed (39 % in NSC-34, 67 % in
WT-NSC, and 56 % in G93A-NSC). The presence of
the M+5 isotopologue of glutamine in cells grown on
[U-13C6]glucose (Fig. 12a) indicated the activity of glutamine
synthetase (GS). However differences in the overall 13C
Fig. 9 Protein expression of hypoxia-inducible factor 1 α and
peroxisome proliferator-activated receptor γ co-activator-1α in the
nuclei of NSC-34, wtSOD1, and G93ASOD1 cells. The NSC-34, WT-
NSC, and G93A-NSC cell lines were cultured for 22 h without serum.
Protein expression in nuclear lysates of a hypoxia-inducible factor 1 α
(HIF-1α; n=6) and b nuclear peroxisome proliferator-activated receptor
γ co-activator-1α (PGC-1α; n=10) were determined byWestern blot and
normalized to actin. A representative Western blot is shown for each
protein. P.C. indicates a positive control sample, i.e., a cell lysate of
NSC-34 cells treated with 1 mM dimethyloxaloylglycine (DMOG) for
4 h for HIF-1α and a cell lysate of DU145 cells for PGC-1α. Mean ±
s.e.m. percentages of the NSC-34 level are shown (*p<0.05, and
***p<0.001 after one-way ANOVA and Tukey’s post hoc test)
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enrichment of glutamine among the three genotypes could not
be attributed to different protein expression levels of GS
(Supplementary Fig. 7), suggesting that wtSOD1 increases
glutamine transport into the cell and/or affects glutaminase
activity. Surprisingly, the differences had no effect on overall
13C enrichment of the glutamate pool (Fig. 12a).
Besides being involved in the synthesis of TCA cycle me-
tabolites (Fig. 5) or in glutamine metabolism (Fig. 12a), glu-
tamate plays a role in other metabolic pathways [34] including
the synthesis of other amino acids (serine and glycine) and of
the antioxidant glutathione. We examined the level of 13C
enrichment from labeled glucose or glutamine of the intracel-
lular pools of serine and glycine, which are formed sequen-
tially, and of cystathionine, the precursor of cysteine
(Fig. 12b). Glycine and cysteine, with glutamate, are also pre-
cursors of glutathione. Production from glucose contributed to
a larger percentage of glutamate, glycine, and cystathionine
than glutamine. There was also a marked and significant in-
crease in 13C enrichment of serine and glycine from labeled
glucose in both the WT-NSC and G93A-NSC, compared to
NSC-34, with significantly more labeling from glucose in
G93A-NSC than in WT-NSC (Fig. 12b), confirming the acti-
vation of serine synthesis by serum deprivation in the SOD1-
transfected lines (Fig. 4a). 13C enrichment of cystathionine
was also significantly increased in both WT-NSC and
G93A-NSC (more marked in the latter) suggesting that gluta-
thione synthesis might be increased by serum deprivation in
these lines, more than in NSC-34. Activation of serine and
glutathione synthesis in the WT-NSC and G93A-NSC may
help explain why 13C enrichment of the glutamate pool in
these lines was comparable to that of the NSC-34 (Fig. 12a).
Discussion
Clinical and experimental evidence indicate that defects in
energy metabolism may be pathogenic in ALS [7, 8]. The
dysfunction of motor neuron mitochondria typical of this dis-
ease [4, 5] may play a contributory role, as neurons rely on
mitochondrial oxidative phosphorylation as their main source
of energy [30]. Bioenergetic defects have previously been
described in motor neuronal cells expressing different mutant
forms of SOD1 including G93ASOD1, as well as in fibro-
blasts isolated from ALS cases, expressing I113T SOD1,
and the adaptation of energymetabolism in response to stimuli
was associated with toxicity [6, 20, 35].
The present study employed a well-characterized motor
neuronal ALS model expressing the mutant G93ASOD1 in
the NSC-34 cell line, a spinal cord neuron-neuroblastoma hy-
brid, which has become the most widely used line to study
mechanisms of motor neuron degeneration. The degree of
functional relevance of results in proliferating cell lines in
comparison to those in non-dividing cells may vary; however,
the cell lines are suited for high-throughput analysis as they
can be propagated without limitation. In studies such as ours, a
particular concern will be the impact of metabolic alterations
related to oncogenic transformation on the results of a broad
metabolomic analysis.We have focused on changes relating to
the expression of mutant human SOD1 in comparison with
Fig. 10 Lactate accumulation in the G93A-NSC cell line is associated
with pyruvate dehydrogenase kinase 1 induction and treatment with
dichloroacetate lowers the lactate level. Levels of a pyruvate
dehydrogenase α 1 subunit (PDH; n=3) and b pyruvate dehydrogenase
kinase 1 (PDK1; n=12) of NSC-34, WT-NSC, and G93A-NSC cell lines
cultured for 22 h without serum were determined by Western blot and
normalized to actin. Percentages of the NSC-34 level are shown and a
representative Western blot for each protein (***p<0.001 after one-way
ANOVA and Tukey’s post hoc test). c Time-course (3 and 22 h) of PDK1
levels (normalized to actin; n=3) of NSC-34, WT-NSC, and G93A-NSC
cell lines cultured without serum (*p<0.05 and **p<0.01 by Student’s t
test). d Levels of lactate (μmol/mg of proteins; n=3) in the medium of
WT-NSC and G93A-NSC cultured without serum for 46 h with/without
the PDK1 inhibitor sodium dichloroacetate (DCA; 2.5 and 5 mM;
*p<0.05 and ***p<0.001 after one-way ANOVA and Tukey’s post hoc
test). All values are shown as mean ± s.e.m
2234 Mol Neurobiol (2016) 53:2222–2240
both the expression of wild-type human SOD1 and the
untransfected line, in order to limit the impact of the neuro-
blastoma phenotype on interpretation. In addition, evidence
from a recent deep proteomic comparison of primary motor
neurons and NSC-34 cells indicates that metabolic and house-
keeping pathways are conserved as regards the proteins in-
volved and their abundance [36], suggesting that the NSC-
34 line may continue to be useful for such metabolic
investigations.
We generated a detailed characterization of metabolism
through untargeted metabolite profiling and stable isotope-
incorporation analysis using 1HN MR spectroscopy and GC-
MS. This approach enabled us to assess the effect of mutant
SOD1 on interacting metabolic pathways supported by glu-
cose and glutamine and provided measurements of novel met-
abolic changes. The results suggest links between different
alterations such as mitochondrial dysfunction, oxidative
stress, and impairment of the endoplasmic reticulum (ER)
stress response, which are associated with neurodegeneration
in ALS patients [37, 4] and are seen in animal and cellular
models of ALS-expressing mutant forms of SOD1 [38].
The initial observation was that under serum deprivation,
glycolytic protein expression, and glycolytic flux to lactate
were increased in both WT-NSC and G93A-NSC compared
to the untransfected line. This appears consistent with the pro-
posed role of SOD1 to repress glucose-mediated respiration
[3]. We and other groups have previously shown that even
under basal conditions, G93ASOD1 and other mutant
SOD1s increase the formation of ROS and reactive nitrogen
species and alter mitochondrial morphology in the NSC-34
line [13, 14, 39]. Serum deprivation also substantially in-
creases the formation of ROS and reactive nitrogen species
[14, 40], which are known inhibitors of the mitochondrial
electron transport chain complexes [41]. This increase in
ROS formation may trigger SOD1 regulation of respiration
and hence glycolysis, as SOD1-mediated signaling occurs
through stabilization of casein kinase 1-γ homologs by cata-
lyzing superoxide conversion to peroxide [3]. HIF-1α stabili-
zation was also more marked in both theWT-NSC and G93A-
NSC than in the untransfected line, suggesting the develop-
ment of a pseudo-hypoxic state. However, there was no clear
difference in HIF-1α levels between WT-NSC and G93A-
NSC, indicating that pseudohypoxia was being caused by
SOD1 overexpression, but was not leading to the excess lac-
tate production in the G93A-NSC. Under normoxic condi-
tions, high hydrogen peroxide levels can act as a hypoxia
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mimetic, promoting HIF-1α stabilization [42]. In the WT-
NSC and G93A-NSC, the accumulation of pyruvate and fu-
marate may also contribute to the HIF-1α increase as these
metabolites can compete with the substrate α-ketoglutarate in
the hydroxylation reaction by which the HIF prolyl-
hydroxylases target HIF-1α for degradation [43, 22].
Comparison of WT-NSC and G93A-NSC showed that the
specific loss of viability of the G93A-NSC line was accompa-
nied by a significantly higher net flux to lactate in the G93A-
NSC, suggesting that this metabolic change may influence
survival. To explain this change in the G93A-NSC, we
showed that the protein expression levels of PDK1 and
LDHA (which are critical for lactate overproduction) in-
creased while the glucose-derived acetyl-CoA flux into citrate
decreased. PDK1 induction is a HIF-1-mediated response to
mitigate ROS formation by mitochondria primarily utilizing
glucose as a substrate for oxidative phosphorylation [44] by
repressing mitochondrial function and oxygen consumption
as a consequence of the shift of pyruvate to lactate. In the
G93A-NSC, the induction of PDK1 and LDHAmay be driven
by the need to divert pyruvate derived from glycolysis away
from oxidative metabolism and reduce the burden of mito-
chondrial free radical formation. Our results in the G93A-
NSC line agree with findings in fibroblasts from ALS cases
carrying I113T SOD1 showing an increase in glycolytic flux
and a reduction in mitochondrial respiration compared with
fibroblasts from healthy controls [35].
Overexpression of PDK1 and LDHA have been shown to
protect against neuronal death by reducing mitochondrial res-
piration and ROS production and maintaining ATP levels in a
model of Alzheimer’s disease characterized by mitochondrial
dysfunction [45]. In the G93A-NSC cells, the increased gly-
colytic flux may be used to maintain energy generation out-
side of mitochondrial respiration by taking advantage of the
high levels of glucose present in the medium. It must be noted
however, that while 25 mM glucose is used routinely in the
culture of NSC-34 and other primary and immortalized neu-
ronal culture, this is not entirely reflective of in vivo condi-
tions. Further in vivo investigation into this adaptation will
provide a clearer picture into the extent by which it may be
observed in neuronal cells and impact the disease process.
Additional evidence of the adaptations to oxidative stress
in the G93A-NSC line comes from the increase of PGC-1α,
which can upregulate the expression of ROS-detoxifying en-
zymes to protect neural cells from cytotoxicity due to oxida-
tive insult [26]. In our model, the increase in PGC-1α was
parallel to that of lactate, making it unlikely that it was related
to the stimulation of respiration [25]. However, despite these
metabolic adaptations to mitigate mitochondrial ROS produc-
tion, the increased glycolytic flux to lactate induced by wt/
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G93ASOD1 could paradoxically make the motor neuronal
cells more vulnerable to the effects of oxidative stress by re-
ducing pentose phosphate pathway (PPP) flux. In cortical neu-
rons, the capacity to metabolize glucose through glycolysis
was reported to be low, with glucose being used extensively
in the PPP to build up reducing power (NADPH). The NADP
H, in turn, is used to replenish the pool of reduced glutathione,
the major cell antioxidant, and activation of neuronal glycol-
ysis (via Pfkfb3) led to increased oxidative stress and apopto-
sis [46]. An increased flux of glucose through glycolysis may
then limit that through PPP, increasing susceptibility to oxida-
tive stress.
This possibility is consistent with the observation that sys-
temic administration of DCA, the PDK1 inhibitor used in the
present study, increased survival of the G93ASOD1 mouse
[47]. This effect was apparently due to modification of the
mitochondrial function of astrocytes, reducing astrocyte reac-
tivity and preventing motor neuron loss. PDH phosphoryla-
tion in the astrocytes was decreased by DCA treatment, sug-
gesting that modulation of PDK1 induction may hold poten-
tial as a therapeutic strategy for future investigation.
The WT-NSC and G93A-NSC lines also had increased
biosynthesis from glucose of glutamine (which leads to gluta-
mate), glycine, and serine and cystathionine (both leading to
cysteine) than the untransfected line. This suggests that over-
expression of SOD1 might support the glutathione synthesis
necessary to counteract serum deprivation-induced oxidative
stress by driving de novo synthesis of amino acid precursors
of this cellular antioxidant. However, when considering the
total pool of each amino acid precursor of glutathione, we only
observed an increase in the WT-NSC line compared to the
NSC-34; the G93A-NSC also had a smaller pool of cystathi-
onine. The size of these pools may be a previously unrecog-
nized limiting factor contributing to trigger oxidative stress, as
a decrease in glutathione was reported in cell models with
prolonged exposure/high level of mutant G93ASOD1 [48]
and during disease progression in the G93ASOD1 mouse
[49]. The increased serine in the WT-NSC and G93A-NSC
lines is compatible with that of 3-phosphoglycerate in these
lines, and indicates the induction of serine synthesis. This
effect has previously been observed at disease onset in motor
neurons of G37RSOD1 mice [50] and is regulated by a sensor
of non-essential amino acid starvation through the GCN2-
ATF4 pathway [23]. L-Serine also has a versatile role in inter-
mediary metabolism, particularly in neuronal tissue, as it is a
precursor of D-serine and glycine, both NMDA receptor co-
agonists. In the G93ASOD1 mouse spinal cord, D-serine
levels were progressively elevated [51]. Alterations to D-ser-
ine homeostasis have been implicated in the development of
ALS, since some cases of fALS have a mutation in D-amino
acid oxidase, which impairs the activity of this enzyme [52].
However, although we saw high levels of serine, we could not
resolve chiral species with the metabolomic method applied.
More precise measurements for each chiral species would be
required to identify the specific contributions of the D- and L-
stereoisomers.
Regulation of lactate levels is also an important factor in
supporting neuronal survival. Disruption of lactate transport in
experimental models leads to axon damage and neuron loss,
and MCT1 levels were low in ALS patients [11]. We did not
see any reduction of this transporter in the G93A-NSC line
under serum deprivation, but the shift towards increased lac-
tate production and release may affect the glutamine-
glutamate cycle and the prevention of excitotoxicity. In astro-
cytes, glutamate uptake is coupled with a shift in glycolysis
towards lactate production [53] while in neurons, increasing
lactate uptake through increased monocarboxylate transporter
2 expression can prevent glutamate-mediated excitotoxicity
[54]. In the motor neuronal G93A-NSC line, as it presented
a significant increase in net lactate output, the preference was
for clearance of lactate rather than utilization.
The NSC-34 cell line has very low sensitivity to glutamate
[55] so it is unlikely that excitotoxicity played a role in cell
death in our model. However, increased net lactate output in
an astrocyte-neuron metabolic interaction in vivo may com-
promise glutamate uptake by astrocytes, limiting its synaptic
clearance. This, coupled with the greater glutamate release in
the G93A-NSC compared to WT-NSC, suggests that the met-
abolic changes due to mutant SOD1 expression may poten-
tially increase motor neuron susceptibility to glutamate-
mediated excitotoxicity.
The other main metabolic change was a general and signif-
icant depletion of amino acid pools in the G93A-NSC. Serum
deprivation has been reported to induce ER stress, which ac-
tivates the PERK/eIF2α/ATF4-dependent ISR [32] in an at-
tempt to balance the accumulation of misfolded proteins in the
ER. The PERK pathway is one of three that make up the
unfolded protein response (UPR), and promotes amino acid
sufficiency for the synthesis of protective proteins, and in fact,
amino acid pools were larger in the WT-NSC than in G93A-
NSC. ER stress, UPR, and activation of ISR are present in
models expressing mutant SOD1 and in ALS patients [56, 1].
The exact mechanism through which mutant SOD1 causes ER
stress is not known, although several studies suggest that
misfolded mutant SOD1 is present in the ER lumen [56]. In
our model, it is hard to see whether there are misfolded pro-
teins and/or aggregates because of the low expression level of
the mutant protein [13]. However, our results suggest that
dysregulation of glucose metabolism by G93ASOD1 poten-
tially alters the cell’s ability to maintain the UPR. A role for
the PERK pathway has been identified in the pathogenesis of
mutant SOD1-linked fALS and holds potential as a target for
treatment [57]. The metabolic phenotype we observed in the
G93A-NSC line would be compatible with down regulation of
proteins involved in amino acid import and metabolism, as
shown in Perk−/− cells [33] which have impaired ISR.
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The amino acid depletion in the G93A-NSC line also sug-
gests impaired autophagy (macroautophagy), which mutant
SOD1 has also been noted to affect [1]. Cells and mice defi-
cient in autophagic genes were unable to maintain the cellular
amino acid pool [58]. Activation of autophagy is a central
component of the ISR and is a response to nutrient deprivation
and to the failure of the ubiquitin-proteasomal system when it
is overwhelmed by misfolded proteins from the ER [59]. In
addition, the activation of selective mitochondrial autophagy
is also a strategy to reduce ROS generation [44]. In our model,
leucine, glutamine, and glutamate were more abundant in the
cells expressing wtSOD1 compared to the cells expressing
G93ASOD1. This suggests the possibility of dysregulation
of mTORC1-mediated autophagy activation, which is con-
trolled by leucine and glutaminolysis [60].
Conclusions
We captured metabolomic changes in motor neuronal cells ex-
pressing wt- andmutant G93ASOD1 exposed to oxidative stress
and ISR activation, as well as selective cell death in cells ex-
pressing the ALS-causing mutation. wtSOD1 orchestrated a
metabolic rearrangement based on increased glucosemetabolism
which coordinated promotion of resistance to oxidative stress
and amino acid depletion/ER stress. In the presence of the mu-
tant SOD1, this program failed and turned into cytotoxicity. Our
results provide fresh insights into the mechanisms by which
defective regulation of metabolism by G93ASOD1 could pro-
mote motor neuron death and disease progression in ALS.
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